Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty

被引:12
作者
Binion, David G.
Theriot, Kenneth R.
Shidham, Sushrut
Lundeen, Sarah
Hatoum, Ossama
Lim, Hyun J.
Otterson, Mary F.
机构
[1] Med Coll Wisconsin, Froedtert Hosp, Milwaukee VA Med Ctr, Ctr Digest Dis,Dept Surg,Div Biostat, Milwaukee, WI 53226 USA
[2] Milwaukee VA Med Ctr, Froedtert Hosp, Ctr Digest Dis, Dept Med,Div Gastroenterol & Hepatol, Milwaukee, WI USA
[3] Milwaukee VA Med Ctr, Froedtert Hosp, Ctr Digest Dis, Dept Pathol, Milwaukee, WI USA
关键词
Crohn's disease; surgery; strictureplasty; azathioprine; 6-mercaptopurine; methotrexate; infliximab; adhesions; complications;
D O I
10.1007/s11605-007-0298-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although surgically induced remission of Crohn's disease following segmental resection/strictureplasty is effective and durable, a subpopulation of patients will require rapid reoperation. We reviewed our inflammatory bowel disease center's database to identify patients who underwent multiple laparotomies. A retrospective analysis of consecutive Crohn's disease patients (1998-2004) was performed, and patients requiring repeat laparotomy were identified. Rapid reoperation was defined as repeat intestinal surgery within 2 years. Demographic data and medical treatment were recorded. Clinical factors contributing to rapid reoperation were defined as (1) symptomatic adhesion, (2) residual strictures/technical error, (3) lack of effective medical therapy, and (4) severe disease despite medical treatment. Of 432 patients, 65 required two or more abdominal explorations, with 32 patients requiring rapid reoperation (50 surgeries). Residual strictures and technical error accounted for 20% of procedures; ineffective medical therapy was identified in 64%, whereas severe disease despite medical therapy was a contributing factor in 14%. Adhesions were found in a single patient. Kaplan-Meier analysis confirmed that rapid reoperation patients had significant and consistently shorter intervals between surgical procedures (i. e., interval between procedures 1 and 2 and 2 and 3). Residual strictures manifest during postop year 1, whereas recurrence of severe disease was the dominant contributing factor during year 2. Our data suggest that operative strategies emphasizing occult stricture detection and adequate medical therapy in Crohn's disease patients may improve outcome and decrease the need for rapid re- exploration.
引用
收藏
页码:1692 / 1698
页数:7
相关论文
共 36 条
[1]
Risk factors for surgery and postoperative recurrence in Crohn's disease [J].
Bernell, O ;
Lapidus, A ;
Hellers, G .
ANNALS OF SURGERY, 2000, 231 (01) :38-45
[2]
Strictureplasty for large bowel stenosis in Crohn's disease:: quality of life after surgical therapy [J].
Broering, DC ;
Eisenberger, CF ;
Koch, A ;
Bloechle, C ;
Knoefel, WT ;
Dürig, M ;
Raedler, A ;
Izbicki, JR .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (02) :81-87
[3]
A CONTROLLED DOUBLE-BLIND-STUDY OF AZATHIOPRINE IN THE MANAGEMENT OF CROHNS-DISEASE [J].
CANDY, S ;
WRIGHT, J ;
GERBER, M ;
ADAMS, G ;
GERIG, M ;
GOODMAN, R .
GUT, 1995, 37 (05) :674-678
[4]
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy [J].
Colombel, JF ;
Loftus, EV ;
Tremaine, WJ ;
Pemberton, JH ;
Wolff, BG ;
Young-Fadok, T ;
Harmsen, WS ;
Schleck, CD ;
Sandborn, WJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (05) :878-883
[5]
Postoperative recurrence of Crohn's disease: Pathophysiology and prevention [J].
D'Haens, G ;
Rutgeerts, P .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (04) :295-303
[6]
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum [J].
D'Haens, GR ;
Geboes, K ;
Peeters, M ;
Baert, F ;
Pennickx, F ;
Rutgeerts, P .
GASTROENTEROLOGY, 1998, 114 (02) :262-267
[7]
De Dombal F T, 1971, Br J Surg, V58, P805, DOI 10.1002/bjs.1800581102
[8]
Dietz DW, 2001, J AM COLL SURGEONS, V192, P330, DOI 10.1016/S1072-7515(01)00775-X
[9]
Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease - Reply [J].
Dietz, DW ;
Lauretti, S ;
Strong, SA ;
Hull, TL ;
Church, J ;
Remzi, FH ;
Lavery, IC ;
Fazio, VW .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2001, 192 (03) :337-338
[10]
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease [J].
Dubinsky, MC ;
Lamothe, S ;
Yang, HY ;
Targan, SR ;
Sinnett, D ;
Théorêt, Y ;
Seidman, EG .
GASTROENTEROLOGY, 2000, 118 (04) :705-713